Berberis Vulgaris Consumption and Blood Pressure
Palabras clave
Abstracto
fechas
| Verificado por última vez: | 03/31/2020 |
| Primero enviado: | 09/02/2019 |
| Inscripción estimada enviada: | 09/06/2019 |
| Publicado por primera vez: | 09/09/2019 |
| Última actualización enviada: | 04/10/2020 |
| Última actualización publicada: | 04/13/2020 |
| Fecha de inicio real del estudio: | 09/17/2019 |
| Fecha estimada de finalización primaria: | 03/18/2020 |
| Fecha estimada de finalización del estudio: | 05/31/2020 |
Condición o enfermedad
Intervención / tratamiento
Dietary Supplement: Barberry
Dietary Supplement: placebo
Fase
Grupos de brazos
| Brazo | Intervención / tratamiento |
|---|---|
| Active Comparator: Barberry Daily consumption of barberry in powder form. | Dietary Supplement: Barberry 10 grams of barberry powder will be consumed daily for 8 weeks. |
| Placebo Comparator: placebo Daily consumption of placebo powder. | Dietary Supplement: placebo Placebo powder |
Criterio de elegibilidad
| Edades elegibles para estudiar | 20 Years A 20 Years |
| Sexos elegibles para estudiar | All |
| Acepta voluntarios saludables | si |
| Criterios | Inclusion Criteria: - willingness to participate in the study - age between 20-65 years - having elevated BP (129/ < 85) and known hypertensive patients on medical treatment - at least one other classical cardiovascular disease risk factors, including hyperlipidemia or diabetes mellitus Exclusion Criteria: - Unwillingness to continue participation - BMI> 30 - patients on nitrates - high doses of statins consumption (Atorvastatin>40 mg/day or Rosuvastatin>20 mg/day) - consumption of vitamins or minerals supplements during past month - Chronic kidney disease stage 4 or 5 |
Salir
Medidas de resultado primarias
1. blood pressure [at 8 weeks]
Medidas de resultado secundarias
1. lipid profile [at 8 weeks]
2. plasma NOx [at 8 weeks]
3. Inflammatory cytokine [at 8 weeks]
